Skip to main content

Advertisement

SpringerLink
Log in

Killing Two Birds with One Stone: the Therapeutic Role of Ibrutinib in Schnitzler Syndrome

  • Letter to Editor
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Data Availability

Not applicable.

Code Availability

Not applicable.

References

  1. Claves F, Siest R, Lefebvre C, Valmary-Degano S, Carras S. Dramatic efficacy of ibrutinib in a Schnitzler syndrome case with indolent lymphoma. J Clin Immunol. 2021;41(6):1380–3. https://doi.org/10.1007/s10875-021-01038-y.

  2. Pathak S, Rowczenio D, Lara-Reyna S, et al. Evidence of B cell clonality and investigation into properties of the IgM in patients with Schnitzler syndrome. Front Immunol. 2020;11:569006.

    Article  CAS  Google Scholar 

  3. Liu X, Pichulik T, Wolz O-O, et al. Human NACHT, LRR, and PYD domain-containing protein 3 (NLRP3) inflammasome activity is regulated by and potentially targetable through Bruton tyrosine kinase. J Allergy Clin Immunol. 2017;140(4):1054–1067.e10.

    Article  CAS  Google Scholar 

  4. Pathak S, Rowczenio DM, Owen RG, et al. Exploratory study of MYD88 L265P, rare NLRP3 variants, and clonal hematopoiesis prevalence in patients with Schnitzler syndrome. Arthritis Rheumatol. 2019;71(12):2121–5.

    Article  CAS  Google Scholar 

  5. Einhaus J, Pecher A-C, Asteriti E, et al. Inhibition of effector B cells by ibrutinib in systemic sclerosis. Arthritis Res Ther. 2020;22(1):66.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL, 33606, USA

    Chen Wang

Authors
  1. Chen Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chen Wang.

Ethics declarations

Ethics Approval

Not applicable.

Consent to Participate

Not applicable.

Consent for Publication

Not applicable.

Conflict of Interest

None.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, C. Killing Two Birds with One Stone: the Therapeutic Role of Ibrutinib in Schnitzler Syndrome. J Clin Immunol 41, 1706–1707 (2021). https://doi.org/10.1007/s10875-021-01105-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-021-01105-4

Search

Navigation